PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,588,000 | -29.2% | 417,655 | -5.3% | 0.00% | 0.0% |
| Q4 2019 | $2,243,000 | -2.6% | 440,841 | -3.3% | 0.00% | 0.0% |
| Q3 2019 | $2,304,000 | -19.0% | 455,763 | -1.1% | 0.00% | 0.0% |
| Q2 2019 | $2,843,000 | +26.6% | 460,653 | -4.8% | 0.00% | 0.0% |
| Q1 2019 | $2,245,000 | +13.0% | 483,996 | +2.3% | 0.00% | 0.0% |
| Q4 2018 | $1,987,000 | -33.3% | 473,149 | -0.5% | 0.00% | 0.0% |
| Q3 2018 | $2,981,000 | -9.3% | 475,354 | +16.3% | 0.00% | 0.0% |
| Q2 2018 | $3,287,000 | +19.1% | 408,834 | +10.5% | 0.00% | 0.0% |
| Q1 2018 | $2,759,000 | +28.5% | 369,939 | +2.5% | 0.00% | 0.0% |
| Q4 2017 | $2,147,000 | -19.9% | 360,809 | -1.0% | 0.00% | 0.0% |
| Q3 2017 | $2,682,000 | +7.5% | 364,432 | -0.8% | 0.00% | 0.0% |
| Q2 2017 | $2,495,000 | -28.1% | 367,459 | -0.1% | 0.00% | -50.0% |
| Q1 2017 | $3,472,000 | +2125.6% | 367,798 | +893.1% | 0.00% | – |
| Q2 2016 | $156,000 | -4.9% | 37,037 | -1.6% | 0.00% | – |
| Q1 2016 | $164,000 | -29.6% | 37,639 | -0.9% | 0.00% | – |
| Q4 2015 | $233,000 | -83.1% | 37,997 | -84.2% | 0.00% | -100.0% |
| Q3 2015 | $1,377,000 | -30.7% | 240,733 | -9.6% | 0.00% | 0.0% |
| Q2 2015 | $1,987,000 | +59.9% | 266,370 | +28.2% | 0.00% | 0.0% |
| Q1 2015 | $1,243,000 | -14.0% | 207,786 | +8.6% | 0.00% | 0.0% |
| Q4 2014 | $1,446,000 | – | 191,273 | +1912630.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 10 | -99.9% | 0.00% | – |
| Q3 2013 | $34,000 | +142.9% | 6,836 | +114.8% | 0.00% | – |
| Q2 2013 | $14,000 | – | 3,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|